Company Overview
| Stock Name | 四環醫藥控股集團有限公司 |
|---|---|
| Stock Code | 00460 |
| Company Full Name | 四環醫藥控股集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事藥物研發、生產及銷售。 |
| Listing Date | 2010-10-28 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港灣仔港灣道1號會展廣場辦公大樓4905室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.sihuanpharm.com |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 4.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 27.8% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 2,875,000,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 5.77 |
|---|---|
| First Day Open | HK$ 6.05 |
| First Day Change | 25.43% |
| First Day Volume | 804820000.0 |
| First Day Turnover | 4724570000.0 |
Use of Proceeds
| Use of Proceeds | 1、約20%或1101.0百萬港元，將用于研發: a.約10%或550.5百萬港元，將用于撥付我們的產品開 發及研究； b.約10%或550.5百萬港元，將用于開發我們現有的候 選產品 2、約15%或825.7百萬港元，將用于收購能補充及擴展我們現有產品組合的特定產品或生產線； 3、約15%或825.7百萬港元，將用于向建設位于廊坊及北京的兩項新生產設施所需的資本開支提供資金； 4、約30%或1651.4百萬港元，將用于我們發現適當的目標公司或業務進行上述活動時可能產生的并購機會； 5、約10%或550.5百萬港元，將用于加大銷售及分銷力度； 6、約10%或550.5百萬港元，將用作營運資金及一般公司開支。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
UBS Securities Hong Kong Limited CE BIN466
Overall Coordinators (2)
摩根士丹利亚洲有限公司 CE AAD291
UBS Securities Hong Kong Limited CE BIN466
Joint Bookrunners (2)
摩根士丹利亚洲有限公司 CE AAD291
UBS Securities Hong Kong Limited CE BIN466
Joint Lead Managers (3)
摩根士丹利亚洲有限公司 CE AAD291
UBS Securities Hong Kong Limited CE BIN466
大和资本市场香港有限公司 CE AAB639
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Gaoling Fund, L.P. | 378,718,000 HKD | — | 6.60% | — | 6 months | 2011-04-28 |
| 2 | Quantum Partners LP | 336,637,200 HKD | — | 5.90% | — | 6 months | 2011-04-28 |
| 3 | 惠理基金管理香港有限公司 | 168,318,600 HKD | — | 2.90% | — | 6 months | 2011-04-28 |
| 4 | 建银国际资产管理有限公司 | 126,237,800 HKD | — | 2.20% | — | 6 months | 2011-04-28 |
| 5 | 云峰基金 | 168,318,600 HKD | — | 2.90% | — | 6 months | 2011-04-28 |
| 6 | 中国人寿保险(海外)股份有限公司 | 168,318,600 HKD | — | 2.90% | — | 6 months | 2011-04-28 |
| 7 | 中国人寿保险(集团)公司 | 252,480,200 HKD | — | 4.40% | — | 6 months | 2011-04-28 |
Directors & Management
| Chairman | 車馮升 |
|---|---|
| Company Secretary | 陳燕玲,李健威 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 車馮升(55.02%) |
|---|
